← SCP Cost Explorer Read on SCP Wiki ↗
SCP-129 Keter ? low confidence
SCP-129
Expected annual
$15.6B
One-time setup
$11.6B
Annual recurring
$14.5B
Personnel
14250
One-time establishment and contingency reserves total roughly $11.56B, dominated by contingency, insurance seed, research startup, and facility buildouts; annual recurring costs are ~ $14.48B/yr driven primarily by staff wages, indirect economic impact, compensation/social support, security, medical operations, and long-term environmental programs.
🏗️ One-Time Capital Costs Total: $11.6B
Contingency High Severity $10.0B
[#30] Strategic contingency reserve for Stage Four/Five extreme measures (documented as open-ended; lower-bound contingency provision included).
Insurance Seed $500.0M
[#26] Seed insurance and indemnity reserve fund (one-time seed to cover early claims and legal liabilities).
Initial Research And Lab Setup $430.0M
[#12, #13, #22] Initial research program and lab buildout costs: sequencing platforms and bioinformatics capital, R&D program startup for therapeutics/vaccine trials, and initial training/certification programs.
Facilities $283.0M
[#1, #3, #5, #17, #23, #24, #25, #27] Capital construction and structural work: regional incident command centers, build/upgrade of multiple high-containment labs (BSL-3/4), quarantine/isolation room conversions, incinerator/autoclave site installs, HVAC/HEPA retrofits, initial IT/data facilities, biobank facility, and warehouse/stockpile network.
Initial Stockpile $200.0M
[#14] Initial stockpiling of treatment courses and supplies (one-time purchase of courses/devices to establish baseline national stockpile).
Equipment $114.0M
[#9, #10, #15, #23, #25] Capital equipment purchases: diagnostic qPCR/automation platforms, mobile labs and isolation ambulances, PAPRs and reusable PPE equipment, UV-C decontamination units, and cold-storage freezers.
Manufacturing Capacity $30.0M
[#14] One-time manufacturing capacity upgrades to enable mass production of treatments and packaging/cold-chain infrastructure.
🔄 Annual Recurring Costs Total: $14.5B/yr
Indirect Economic Impact $10.0B/yr
[#29] Indirect GDP and economic losses attributable to ongoing outbreak impacts (business closures, trade disruption); included here as recurring estimated indirect cost.
Compensation And Social Support $1.0B/yr
[#21] Recurring compensation programs and social safety-net payouts (income replacement, business interruption, paid sick leave, quarantinee support).
Staff Wages $970.0M/yr
[#2, #4, #6, #7, #8] Salaries and ongoing personnel costs: incident command/coordination staff, specialized BSL-3/4 operations staff, quarantine/isolation ward staffing, core clinical personnel package (physicians, nurses, techs, specialists), and large-scale security/enforcement payroll.
Animal Control And Veterinary $700.0M/yr
[#19] Recurring animal diagnostics, humane culling operations, carcass disposal, veterinary response, and farmer compensation programs.
Supplies And Consumables $601.0M/yr
[#9, #11, #17, #25] Recurring consumables: disposable PPE consumption, testing reagents/swabs/consumables, routine biohazard disposal costs, and cold-storage energy/maintenance.
Environmental Decontamination $500.0M/yr
[#18] Recurring environmental remediation and large-scale decontamination campaigns (urban/rural fungicide, soil treatment, repeated cleanup operations).
Long Term Recovery $200.0M/yr
[#31] Long-term environmental and public health recovery budgets: ecosystem restoration, mental health services, and sustained monitoring.
Logistics And Transport $180.0M/yr
[#16, #27, #28] Patient and sample transport operations, stockpile warehouse management and rolling replenishment logistics, and international response/coordination travel and shipments.
Research And Monitoring $140.0M/yr
[#12, #13, #24] Ongoing genomic surveillance and sequencing operations, R&D/clinical trial operations and production scaling, and modeling/epidemiology staff and analytics.
Manufacturing And Replenishment $100.0M/yr
[#14] Ongoing manufacturing, replenishment, and scaling costs for therapeutics/antifungal courses and vaccine/treatment production.
Cover Story And Legal $30.0M/yr
[#20] Public health messaging programs, legal defenses, government relations, and any cover/communications costs.
Training And Drills $30.0M/yr
[#22] Annual refresher training, certification renewals, and regular drills for healthcare, lab, security, and decontamination teams.
Insurance Topups $20.0M/yr
[#26] Recurring top-ups to the insurance/indemnity fund to maintain coverage and pay claims.
Facilities Maintenance $12.0M/yr
[#23, #17] Ongoing facility maintenance, HVAC/HEPA filter replacement schedules, utilities and maintenance for incinerators/autoclaves and isolation infrastructure.
⚡ Cost Scenarios
📊 Baseline (baseline) $14.5B/yr
74.5% probability / year
Normal year with ongoing containment, surveillance, treatment, and no major escalations.
stable limited spread routine surveillance no major breaches
🚨 Minor Incident $15.0B/yr
20.0% probability / year +$500.0M vs baseline
Localized surge or cluster requiring targeted surge capacity, extra PPE, testing, limited culling, and short-term social supports.
localized Stage Three outbreak regional hospital surge rapid surge in testing demand
🚨 Major Breach $24.5B/yr
5.0% probability / year +$10.0B vs baseline
Widespread Stage Four outbreak requiring national-scale surge measures, major manufacturing scale-up, mass quarantine, and large culling operations.
multi-regional Stage Four spread mass quarantine required rapid nationwide transmission
🚨 Catastrophic Breach $114.5B/yr
0.5% probability / year +$100.0B vs baseline
Stage Five/global catastrophic actions requiring extreme measures, ecological interventions, mass culling, or geoengineering-scale responses.
uncontrolled Stage Five spread requirement for mass eradication or geoengineering global ecological interventions
👥 Personnel 14250 total
Role Count Notes
Security Officer / MTF Agent 10000 [#8] Estimated frontline guards and enforcement personnel for quarantine sites and movement controls.
Research Scientist 500 [#4, #12] BSL-3/4 laboratory researchers, sequencing and bioinformatics staff.
Research Support / Lab Tech 500 [#4, #10] Laboratory technicians supporting high-throughput diagnostics and sequencing.
Research Scientist (R&D therapeutics) 100 [#13] R&D staff for therapeutics and clinical trial operations.
Medical Officer / Physician 500 [#7] Infectious disease physicians and specialist clinicians (500 used as analyst example).
Nurse / Medical Technician 2000 [#7] Nurses and clinical support staff for isolation wards and patient care.
Incident Command / Administrative Staff 100 [#1, #2] Incident managers, planners, liaison officers, and administrative support.
Support Staff (cleaners, respiratory therapists) 1000 [#6] Ancillary clinical staff required for quarantine ward operations and decontamination.
Engineer / Maintenance 50 [#17, #23] Maintenance staff for HVAC/HEPA, autoclaves, incinerators and facility systems.
Logistics / Supply Chain 400 [#27, #16] Warehouse, transport, and supply-chain personnel.
📋 Confidence Notes
Large ranges in the analyst notes, open-ended contingency for Stage Four/Five, ecological uncertainties, and heavy dependence on outbreak scale produce low confidence in point estimates.
← SCP-128 ↑ All SCPs SCP-130 →